Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Embio
Mumbai, Maharashtra, Indiaembio.co.in ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
Embio is a global pharmaceutical company specializing in the development and large-scale manufacturing of active pharmaceutical ingredients (APIs) and chiral intermediates. The company is recognized as one of the world's largest producers of Ephedrine and Pseudoephedrine salts, serving major pharmaceutical markets including the US, Europe, and Japan. Embio's core expertise lies in complex chemical synthesis and biotechnology-based fermentation processes, particularly in the production of chiral molecules. Beyond its leadership in respiratory and decongestant APIs, the company provides contract manufacturing services and develops advanced intermediates for various therapeutic applications.
- Therapeutic areas
- EndocrinologyPulmonologyCardiovascular
- Modalities
- Small molecule
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Embio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Embio.